Clinical trial
Tolerability of MDMA in Schizophrenia
NCT05770375 is registered in ClinicalTrials.gov with Anya Bershad, MD, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerability of MDMA in Schizophrenia
- Lead sponsor
- Anya Bershad, MD, PhD
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- September 1, 2024
- Completion date
- March 1, 2028
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.